Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NVIDIA
NVDA
5
Broadcom
AVGO
US Stock MarketDetailed Quotes
Petros Pharmaceuticals (PTPI)
- 0.0085
- +0.0000+0.30%
15min DelayClose Jan 15 14:48 ET
358.05KMarket Cap0.00P/E (TTM)
0.0086High0.0084Low69.79KVolume0.0084Open0.0084Prev Close590.84Turnover0.17%Turnover Ratio0.00P/E (Static)42.37MShares16.250052wk High0.11P/B357.34KFloat Cap0.001752wk Low--Dividend TTM42.29MShs Float1489.9750Historical High--Div Yield TTM2.37%Range %0.0010Historical Low0.0080Avg Price1Lot Size
Petros Pharmaceuticals (PTPI) Key Financial Indicators
PTPI Earnings per Share (EPS)
According to the latest financial report of Petros Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
PTPI Free Cash Flow (FCF)
Interested in knowing about Petros Pharmaceuticals's free cash flow? The latest report shows it as -1.13M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
PTPI Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Petros Pharmaceuticals shows that the company's current ratio is 2.22, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
PTPI Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Petros Pharmaceuticals, the quick ratio is 2.20, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
PTPI Return on Equity (ROE)
Want to learn more about the financial health of Petros Pharmaceuticals? The latest ROE figure is -29.53%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
PTPI Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Petros Pharmaceuticals, the total asset return on investment (ROA) is -17.06%.
Currency: USD
Quarterly
Loading...
PTPI Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Petros Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 9.01%.
Currency: USD
Quarterly
Loading...
PTPI Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Petros Pharmaceuticals, the net profit margin is -1.28K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?